FDA Inspection 1177362 — Medivance Instruments Ltd.

Medivance Instruments Ltd. — FEI 3003982003

The FDA completed an inspection of Medivance Instruments Ltd. on August 11, 2022 in London. The inspection was classified OAI (Official Action Indicated — objectionable conditions were found and regulatory action is recommended). 6 citations were issued during this inspection. Product area: Devices.

Inspection Details

Classification
Official Action Indicated (OAI) (OAI)
End Date
August 11, 2022
Fiscal Year
2022
Product Type
Devices
Project Area
Compliance: Devices
Location
London (United Kingdom)

Citations

IDCFRDescription
310321 CFR 820.30(i)Design changes - Lack of or Inadequate Procedures
311721 CFR 820.70(i)Software validation for automated processes
313021 CFR 820.100(a)Lack of or inadequate procedures
316021 CFR 820.184Lack of or inadequate DHR procedures
317121 CFR 820.198(b)Rationale documented for no investigation
73221 CFR 803.50(a)(2)Individual Report of Malfunction